Mouse models with AD mutations have shown an inversecorrelation between Aβ levels and GLT-1 function,, however, all of these models had overexpression of familial AD mutations,thus, leading to severe plaque accumulation and neural dysfunction,which must be considered with caution when translating to clinicalAD. Here, SLC1A2 is linked to Alzheimer disease.